{"symbol":"ISRG","fiscalQuarter":"Q2-2026","reportDate":"2026-07-21","reportTime":"AMC","status":"upcoming","company":{"name":"Intuitive Surgical, Inc.","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ISRG/earnings/Q2-2026","estimates":{"consensusEps":2.4971,"consensusRevenue":2818.79,"epsLow":2.41,"epsHigh":2.6,"whisperEps":null,"numAnalysts":null},"preBrief":{"companySnapshot":"Intuitive Surgical, Inc. (ISRG) is a leader in robotic-assisted surgical systems, particularly known for its da Vinci Surgical System. Operating in the Health Care Equipment sector, the company plays a crucial role in advancing minimally invasive surgery, which can lead to quicker recovery times and better patient outcomes.","keyMetrics":[{"name":"EPS","why":"Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.","consensus":"$2.50"},{"name":"Revenue","why":"Total revenue reflects the overall sales performance and demand for Intuitive Surgical's products and services.","consensus":"$2.8B"}],"lastQuarterRecap":{"summary":"In Q1-2026, Intuitive Surgical reported an EPS of $2.50, significantly exceeding estimates by 53.66%. However, the stock saw a decline of 3.07% the following day, indicating potential market skepticism despite strong earnings.","promises":[]},"wallStreetExpectations":{"summary":"Analysts expect strong earnings again this quarter, with a consensus EPS of $2.50 and revenue of $2.8 billion. The company has consistently beaten earnings expectations in recent quarters, which adds to the optimism.","bullCase":"If Intuitive Surgical continues its trend of beating earnings expectations, it could signal robust demand for its surgical systems and lead to a positive stock reaction.","bearCase":"On the flip side, if the company fails to meet expectations or provides cautious guidance, it could lead to a sell-off, especially given the recent stock performance after earnings."},"optionsSignal":{"impliedMove":"1.91%","context":"The options market is pricing in a modest move around the earnings announcement, suggesting that traders expect some volatility but not a dramatic shift in stock price."},"earningsTrackRecord":[{"quarter":"Q1-2026","epsSurprise":"+53.66%","reaction":"-3.07%"},{"quarter":"Q4-2025","epsSurprise":"+38.18%","reaction":"+0.40%"},{"quarter":"Q3-2025","epsSurprise":"+51.90%","reaction":"+0.93%"},{"quarter":"Q2-2025","epsSurprise":"+43.51%","reaction":"-0.99%"},{"quarter":"Q1-2025","epsSurprise":"+32.80%","reaction":"+2.22%"}],"pivotalQuestions":[{"question":"Will the EPS exceed the consensus estimate of $2.50?","whyItMatters":"A beat on EPS could reinforce the company's strong performance and boost investor confidence."},{"question":"What guidance will management provide regarding future revenue growth?","whyItMatters":"Any insights into future sales trends will be critical for assessing the company's growth trajectory."}],"thesisBreakLevels":{"bullTrigger":"An EPS of $2.60 or higher would confirm the bullish case, indicating strong operational performance.","bearTrigger":"An EPS below $2.41 would support the bearish case, suggesting potential issues in demand or cost management.","context":"The market is keenly focused on whether Intuitive Surgical can maintain its strong earnings momentum amid competitive pressures."},"scenarioPlaybook":{"beatAndRaise":"If Intuitive Surgical beats expectations, history suggests the stock could rise by around 0.93% on the first day, confirming strong demand.","inLineCautious":"If results are in line but management provides cautious commentary, the stock may react neutrally, reflecting uncertainty.","miss":"A miss on earnings could lead to a decline, with history suggesting an average drop of around 0.99% following such outcomes."},"whatTheStreetIsMissing":{"thesis":"The consensus may underestimate the demand for robotic-assisted surgeries, which could lead to higher-than-expected revenue growth this quarter.","supportingPoints":["The company has consistently beaten EPS estimates, indicating stronger operational performance than analysts anticipate.","Recent trends in minimally invasive surgeries suggest increasing adoption of robotic systems, which could drive sales higher.","The options market is pricing a smaller move than historical averages, suggesting potential for a larger reaction."],"riskToConsensus":"If revenue growth exceeds $2.9 billion, it could challenge the current consensus and shift market sentiment."},"whatToListenFor":["Any updates on new product launches or innovations in robotic surgery.","Details on international sales growth and market expansion efforts.","Insights into competitive pressures and how they are being addressed.","Management's outlook on the health care market and its impact on future sales.","Any commentary on cost management and operational efficiencies."],"metaDescription":"Intuitive Surgical (ISRG) reports Q2 2026 earnings July 21. Analysts expect $2.50 EPS on $2.8B revenue. Here's what to watch."}}